Memory Pharmaceuticals Corp. (NASDAQ: MEMY)

Memory Pharmaceuticals Corp. (NASDAQ: MEMY) is a biopharmaceutical company focused on developing novel drugs designed to treat debilitating central nervous system (CNS) disorders, many of which significantly impair memory and other cognitive function. The company utilizes their staff’s expertise of the neuronal pathways involved in memory formation and cognition to identify highly relevant targets. By using in-house expertise in drug discovery and development, Memory Pharmaceuticals has generated a diverse pipeline of promising drug development programs. For further information, visit the Company’s web site at www.memorypharma.com.